AAAAAA

   
Results: 1-12 |
Results: 12
Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene
Authors: Casimiro, DR Tang, AM Perry, HC Long, RS Chen, MC Heidecker, GJ Davies, ME Freed, DC Persaud, NV Dubey, S Smith, JG Havlir, D Richman, D Chastain, MA Simon, AJ Fu, TM Emini, EA Shiver, JW
Citation: Dr. Casimiro et al., Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene, J VIROLOGY, 76(1), 2002, pp. 185-194
Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapy
Authors: Frost, SDW Gunthard, HF Wong, JK Havlir, D Richman, DD Brown, AJL
Citation: Sdw. Frost et al., Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapy, VIROLOGY, 284(2), 2001, pp. 250-258
Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection
Authors: Schacker, T Little, S Connick, E Gebhard, K Zhang, ZQ Krieger, J Pryor, J Havlir, D Wong, JK Schooley, RT Richman, D Corey, L Haase, AT
Citation: T. Schacker et al., Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection, J INFEC DIS, 183(4), 2001, pp. 555-562
Patterns of plasma human immunodeficiency virus type 1 RNA response to antiretroviral therapy
Authors: Huang, W De Gruttola, V Fischl, M Hammer, S Richman, D Havlir, D Gulick, R Squires, K Mellors, J
Citation: W. Huang et al., Patterns of plasma human immunodeficiency virus type 1 RNA response to antiretroviral therapy, J INFEC DIS, 183(10), 2001, pp. 1455-1465
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
Authors: Masur, H Kaplan, JE Holmes, KK Alston, BL Ampel, N Anderson, JR Baker, AC Barr, D Bartlett, JG Bennett, JE Benson, CA Bozzette, SA Chaisson, RE Crumpacker, CS Currier, JS Deyton, L Drew, WL Duncan, WR Eisinger, RW El-Sadr, W Feinberg, J Freedberg, KA Furrer, H Gnann, JW Goldberger, MJ Goldie, S Goosby, EP Gross, PA Hafner, R Havlir, D Hooton, TM Jabs, DA Jacobson, MA Janoff, E Kitahata, M Kovacs, JV Leport, C Levin, MJ Lopez, JC Marco, M Mayers, DL Melnick, DA Mofenson, LM Montaner, JSG Moore, R Neaton, J Nelson, C O'Neill, JF Palefsky, J Pau, A Phair, JP Piscitelli, S Polis, MA Quinn, TC Reiss, P Rimland, D Sears, CL Seeff, L Sepkowitz, KA Slama, TG Sloand, EM Spector, SA Thomas, DL Van Dyke, RB Watts, DH Wheat, LJ Whitcup, SM Williams, P Wright, TC Castro, KG DeCock, KM Dowell, SF Dworkin, MS Dykewicz, C Ellerbrock, T Hajjeh, R Holmberg, S Holtgrave, DR Jaffe, HW Jones, JL Juranek, DD Mast, E Navin, T Pellett, PE Reeves, WC Stewart, JA Villarino, ME
Citation: H. Masur et al., 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, CLIN INF D, 30, 2000, pp. S29-S65
Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy
Authors: Gunthard, HF Wong, JK Spina, CA Ignacio, G Kwok, S Christopherson, C Hwang, J Haubrich, R Havlir, D Richman, DD
Citation: Hf. Gunthard et al., Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy, J INFEC DIS, 181(2), 2000, pp. 522-531
Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: Implications for timingof antiretroviral therapy
Authors: Schacker, T Little, S Connick, E Gebhard-Mitchell, K Zhang, ZQ Krieger, J Pryor, J Havlir, D Wong, JK Richman, D Corey, L Haase, AT
Citation: T. Schacker et al., Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: Implications for timingof antiretroviral therapy, J INFEC DIS, 181(1), 2000, pp. 354-357
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine
Authors: Gulick, RM Mellors, JW Havlir, D Eron, JJ Meibohm, A Condra, JH Valentine, FT McMahon, D Gonzalez, C Jonas, L Emini, EA Chodakewitz, JA Isaacs, R Richman, DD
Citation: Rm. Gulick et al., 3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine, ANN INT MED, 133(1), 2000, pp. 35-39
Rapid screening of phenotypic resistance to nevirapine by direct analysis of HIV type 1 reverse transcriptase activity in plasma
Authors: Vazquez-Rosales, G Lerma, JGG Yamamoto, S Switzer, WM Havlir, D Folks, TM Richman, DD Heneine, W
Citation: G. Vazquez-rosales et al., Rapid screening of phenotypic resistance to nevirapine by direct analysis of HIV type 1 reverse transcriptase activity in plasma, AIDS RES H, 15(13), 1999, pp. 1191-1200
Efficacy of azithromycin in prevention of Pneumocystis carinii pneumonia: a randomised trial
Authors: Dunne, MW Bozzette, S McCutchan, JA Dube, MP Sattler, FR Forthal, D Kemper, CA Havlir, D
Citation: Mw. Dunne et al., Efficacy of azithromycin in prevention of Pneumocystis carinii pneumonia: a randomised trial, LANCET, 354(9182), 1999, pp. 891-895
Sexual transmission and propagation of SIV and HIV in resting and activated CD4(+) T cells
Authors: Zhang, ZQ Schuler, T Zupancic, M Wietgrefe, S Staskus, KA Reimann, KA Reinhart, TA Rogan, M Cavert, W Miller, CJ Veazey, RS Notermans, D Little, S Danner, SA Richman, DD Havlir, D Wong, J Jordan, HL Schacker, TW Racz, P Tenner-Racz, K Letvin, NL Wolinsky, S Haase, AT
Citation: Zq. Zhang et al., Sexual transmission and propagation of SIV and HIV in resting and activated CD4(+) T cells, SCIENCE, 286(5443), 1999, pp. 1353-1357
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
Authors: Masur, H Kaplan, JE Holmes, KK Alston, BL Ampel, N Anderson, JR Baker, AC Barr, D Bartlett, JG Bennett, JE Benson, CA Bozzette, SA Chaisson, RE Crumpacker, CS Currier, JS Deyton, L Drew, WL Duncan, WR Eisinger, RW El-Sadr, W Feinberg, J Freedberg, KA Furrer, H Gnann, JW Goldberger, MJ Goldie, S Goosby, EP Gross, PA Hafner, R Havlir, D Hooton, TM Jabs, DA Jacobson, MA Janoff, E Kitahata, M Kovacs, JV Leport, C Levin, MJ Lopez, JC Marco, M Mayers, DL Melnick, DA Mofenson, LM Montaner, JSG Moore, R Neaton, J Nelson, C O'Neill, JF Palefsky, J Pau, A Phair, JP Piscitelli, S Polis, MA Quinn, TC Reiss, P Rimland, D Sears, CL Seeff, L Sepkowitz, KA Slama, TG Sloand, EM Spector, SA Thomas, DL Van Dyke, RB Watts, DH Wheat, LJ Whitcup, SM Williams, P Wright, TC Castro, KG DeCock, KM Dowell, SF Dworkin, MS Dykewicz, C Ellerbrock, T Hajjeh, R Holmberg, S Holtgrave, DR Jaffe, HW Jones, JL Juranek, DD Mast, E Navin, T Pellett, PE Reeves, WC Stewart, JA Villarino, ME Kaplan, JE
Citation: H. Masur et al., 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, ANN INT MED, 131(11), 1999, pp. 873-908
Risultati: 1-12 |